Futurity March 18, 2025
U. Zurich

Researchers have developed a technology that can be used to test around 25 antibodies simultaneously in a single mouse.

New active ingredients such as antibodies are usually tested individually in laboratory animals.

The new work should not only speed up the research and development pipeline for new drugs, but also hugely reduce the number of laboratory animals required.

Many modern drugs are based on antibodies. These proteins very specifically identify a certain structure on the surface of cells or molecules and bind onto it—this may be a receptor protruding from the cell envelope. For antibodies and other protein-based biotherapeutics, extensive preclinical tests need to be conducted on animals before they can be tested on humans.

Currently, antibody candidates are analyzed...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Pharma, Pharma / Biotech
FTC pauses PBM litigation in win for Caremark, Express Scripts, Optum Rx
Pharma Dodges The Tariff Bullet — But For How Long?
Noom, LillyDirect pharmacy provider partner to increase access to Zepbound
Robots can aid hospital pharmacies in safer and more sustainable cancer drug preparation
PBM Private Labeling Boosts Biosimilars, Raises Concerns

Share This Article